Obesity Treatment Using an Internet-delivered Intervention Based on the Diabetes Prevention Program in Mexican Adults
DPPON-MEX
Efficacy of an Internet-delivered Intervention Based on the Diabetes Prevention Program for Weight Loss in Overweight and Obese Mexican Adults: 3 and 6 Months Randomized Controlled Trial
1 other identifier
interventional
62
1 country
1
Brief Summary
In Mexico, 7 out of 10 adults are overweight or obese. The diseases associated with these conditions (diabetes, cardiovascular disease and some cancers) are those that impact the most on the disability-adjusted life years of Mexicans and on their mortality rates. A reduction in body weight of 5-10% can reduce the incidence of obesity related diseases. The gold standard for treating obesity is an intensive lifestyle change program such as the Diabetes Prevention Program (DPP) whose effectiveness has been evaluated in various formats and populations with positive results, including in Mexico. However, the DPP is not accessible to all sectors of the population. To increase its dissemination, the implementation of online interventions based on the DPP (oi-DPP) has been proposed. A systematic review of oi-DPP showed promising results, however, the evidence is limited and the lack of studies of high methodological quality is highlighted. The main objective of this project is to evaluate the efficacy of an oi-DPP for weight loss in Mexican adults with overweight or obesity at 3 months. The study design is a randomized controlled trial with 2 arms: oi-DPP and wait-list control. A 3 months pilot study (n=30) will be conducted prior to the main study to estimate sample size, considering an alpha error of 0.05 and power of 80%. The primary outcome is the mean change in body weight from baseline to 3 months post-baseline between the 2 groups. Secondarily, differences in biochemical parameters (fasting glucose, total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides and gamma glutamyl transferase) from baseline to 3 months will be evaluated, as well as mean changes from baseline to 3 and 6 months in body mass index, waist circumference, systolic and diastolic blood pressure, depression and quality of life scales and the number of participants achieving a weight loss greater than 5% of initial body weight. Body weight will be also evaluated at 6 months post-baseline. The previous measurements will apply both in the pilot study and the study except for the biochemical parameters that will only be included in the main study. The differences between the 2 groups for each variable will be analyzed using a t test for independent samples, in case of having a parametric sample. Otherwise, the Mann-Whitney U test will be used. Analysis will follow the intent-to-treat principle.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 10, 2018
CompletedFirst Posted
Study publicly available on registry
August 14, 2018
CompletedStudy Start
First participant enrolled
September 17, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2019
CompletedApril 28, 2021
April 1, 2021
11 months
August 10, 2018
April 27, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in body weight
baseline to 3 months
Secondary Outcomes (14)
Change in body weight
baseline to 6 months
Change in body mass index
baseline to 3 months and baseline to 6 months
Change in waist circumference
baseline to 3 months and baseline to 6 months
Change in body fat percentage
baseline to 3 months and baseline to 6 months
Change in the Beck Depression Inventory Scale
baseline to 3 months and baseline to 6 months
- +9 more secondary outcomes
Study Arms (2)
ID-DPP group
EXPERIMENTALInternet-delivered intervention based on the DPP
Wait-list Group
OTHERInterventions
This group will receive a 6 month long online behavioral change protocol adapted from the Diabetes Prevention Program. It includes 18 sessions, 12 delivered weekly (during the first 3 months) and 6 delivered biweekly (during the last 3 month period). A web page will be used to deliver the sessions, while the nutritional counseling will be delivered using video calls via Facebook chat. Participants will receive an hypocaloric (1200-1800 kcal, carbohydrates: 45-65%, fats: 20-35% and protein: 10-35%), personalized diet.
This group will only receive written information with recommendations on healthy eating. When the study has finished this group will receive a behavioral change protocol with nutritional counseling using a face-to-face format.
Eligibility Criteria
You may qualify if:
- Mexican adults (≥ 18 years and ≤60)
- Residents of the city of Hermosillo, Sonora
- Overweight or obese (BMI ≥ 25 and ≤45)
- Internet access at home
- Basic computer skills
- Facebook active account
- Candidates must make records of their food consumption for 5 days.
You may not qualify if:
- Substance abuse
- Consumption of more than 14 alcoholic beverages per week (equivalent to 280 g of alcohol)
- Diagnosis of psychiatric conditions that could prevent adherence to treatment
- Previous diagnosis of medical conditions with significant effect on body weight
- Diagnosis of diabetes
- Systolic blood pressure\> 160 mm / Hg
- Pregnant women who are breastfeeding or who plan to become pregnant during the study period
- Consumption of medications with an effect on body weight such as metformin, orlistat or glucocorticoids.
- Participating in another program to reduce weight or performing structured physical exercise other than walking\> 180 min / week
- Plan to participate in some treatment for weight loss during the study
- Any other condition in which weight loss or physical activity is contraindicated
- Previous diagnosis of kidney failure, cancer or any other condition that requires special treatment
- Relatives participating in the study
- Have plans to change residence
- Criteria of the researcher - for clinical reasons or adherence to the protocol
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centro de Promoción de Salud Nutricional (CPSN)
Hermosillo, Sonora, 83000, Mexico
Related Publications (1)
Ruelas AL, Martinez Contreras TJ, Esparza Romero J, Diaz Zavala RG, Candia Plata MDC, Hingle M, Armenta Guirado B, Haby MM. Factors influencing adults to drop out of intensive lifestyle interventions for weight loss. Transl Behav Med. 2023 Apr 15;13(4):245-254. doi: 10.1093/tbm/ibac112.
PMID: 36694376DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 10, 2018
First Posted
August 14, 2018
Study Start
September 17, 2018
Primary Completion
July 31, 2019
Study Completion
October 30, 2019
Last Updated
April 28, 2021
Record last verified: 2021-04